Lanean...
CMET-24. NEXT-GENERATION EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR LEPTOMENINGEAL CARCINOMATOSIS
EGFR mutation status is strongly correlated with leptomeningeal carcinomatosis in non-small-cell lung cancer. Historically, patients were treated with first-generation EGFR tyrosine kinase inhibitors, however most would eventually develop resistance and disease progression. Therefore, recent interes...
Gorde:
| Argitaratua izan da: | Neuro Oncol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216919/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.236 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|